Holen Sie sich die Stockscreener-App
11.25
0.35%
-0.04
Handel nachbörslich:
11.56
0.31
+2.76%
Schlusskurs vom Vortag:
$11.29
Offen:
$11.4
24-Stunden-Volumen:
630.50K
Relative Volume:
1.30
Marktkapitalisierung:
$916.27M
Einnahmen:
$81.39M
Nettoeinkommen (Verlust:
$-114.20M
KGV:
-7.8931
EPS:
-1.4253
Netto-Cashflow:
$-50.60M
1W Leistung:
+19.81%
1M Leistung:
+52.23%
6M Leistung:
+38.21%
1J Leistung:
+106.42%
1-Tages-Spanne:
$11.07
$11.85
1-Wochen-Bereich:
$8.875
$11.85
52-Wochen-Spanne:
$4.55
$11.85
Meiragtx Holdings Plc Stock (MGTX) Company Profile
Firmenname
Meiragtx Holdings Plc
Sektor
Branche
Telefon
646-860-7985
Adresse
655 THIRD AVENUE, NEW YORK, NY
Compare MGTX vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MGTX
Meiragtx Holdings Plc
|
11.25 | 919.53M | 81.39M | -114.20M | -50.60M | -1.4253 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Meiragtx Holdings Plc Stock (MGTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-10-21 | Eingeleitet | Raymond James | Strong Buy |
| 2024-07-31 | Fortgesetzt | Chardan Capital Markets | Buy |
| 2020-10-23 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-09-15 | Fortgesetzt | BofA Securities | Buy |
| 2019-09-03 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-02-27 | Bestätigt | Chardan Capital Markets | Buy |
| 2018-07-03 | Eingeleitet | Barclays | Overweight |
| 2018-07-03 | Eingeleitet | BofA/Merrill | Buy |
Alle ansehen
Meiragtx Holdings Plc Aktie (MGTX) Neueste Nachrichten
MeiraGTx rises on upcoming phase 1 readout for gene therapy - MSN
MeiraGTx: Turning Dry Mouth Into Liquid Gold (NASDAQ:MGTX) - Seeking Alpha
MeiraGTx Holdings (MGTX) Shares Surge 17% on Upcoming Gene Thera - GuruFocus
MeiraGTx to present 3-year data from xerostomia gene therapy trial - Investing.com India
MeiraGTx sets trial readout for gene therapy (MGTX:NASDAQ) - Seeking Alpha
MeiraGTx to Present 3-Year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia on Thursday, April 16, 2026 - Bitget
Quarterly Recap: What is the earnings history of MeiraGTx Holdings plc2026 Setups & Growth Focused Investment Plans - baoquankhu1.vn
Earnings Recap: How liquid is MeiraGTx Holdings plc stockTrade Exit Report & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Naylor, MeiraGTx chief dev. officer, sells $258,906 in shares By Investing.com - Investing.com Canada
Insider Sell Alert: Stuart Naylor Sells Shares of MeiraGTx Holdings PLC - GuruFocus
MeiraGTx (MGTX) CDO Stuart Naylor sells 27,661 shares via 10b5-1 plan - Stock Titan
Naylor, MeiraGTx chief dev. officer, sells $258,906 in shares - Investing.com
[144] MeiraGTx Holdings plc SEC Filing - Stock Titan
MeiraGTx (NASDAQ:MGTX) Hits New 52-Week HighTime to Buy? - MarketBeat
MeiraGTx (NASDAQ:MGTX) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat
(MGTX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
MGTX Technical Analysis & Stock Price Forecast - Intellectia AI
What Does The Future Hold For MeiraGTx Holdings plc (NASDAQ:MGTX)? These Analysts Have Been Cutting Their Estimates - Sahm
MeiraGTx Holdings plc Ordinary Shares MGTX ) Stock Price Today & Analysis - Gotrade
MeiraGTx Holdings plc Ordinary Shares (MGTX) Stock Price Today & Analysis - heygotrade.com
MGTX: Evercore ISI Group Lowers Price Target for MeiraGTx Hldgs | MGTX Stock News - GuruFocus
MeiraGTx Holdings PLC $MGTX Shares Bought by Hennion & Walsh Asset Management Inc. - MarketBeat
MGTX: Evercore ISI Group Lowers Price Target for MeiraGTx Hldgs - GuruFocus
Strength Displayed by MeiraGTx (MGTX): Will Its 6.2% Surge Lead to Further Gains? - Bitget
Strength Seen in MeiraGTx (MGTX): Can Its 6.2% Jump Turn into More Strength? - Yahoo Finance
Performance Recap: Can MeiraGTx Holdings plc deliver consistent EPS growth2026 Rallies & Community Trade Idea Sharing Platform - baoquankhu1.vn
MeiraGTx Holdings plc (NASDAQ:MGTX) Analysts Are Cutting Their Estimates: Here's What You Need To Know - simplywall.st
MeiraGTx Holdings plc (NASDAQ:MGTX) Just Reported And Analysts Have Been Cutting Their Estimates - Yahoo Finance
MeiraGTx 2025 Annual Report Highlights: Gene Therapy Pipeline, Strategic Partnerships, and Proprietary Riboswitch Platform - Minichart
MeiraGTx 2025 10-K: Revenue $81.4M, EPS (1.42) - TradingView
MeiraGTx (NASDAQ: MGTX) expands gene therapy partnerships and manufacturing - Stock Titan
MeiraGTx Holdings plc (MGTX) Stock Price Prediction: Today, Tomorrow, Next Week - Traders Union
Live MeiraGTx Holdings plc (MGTX) Technical Analysis - tradersunion.com
Bank of America Forecasts Strong Price Appreciation for MeiraGTx (NASDAQ:MGTX) Stock - Defense World
MeiraGTx Holdings plc (MGTX) Stock Price, News, Quote & History - Yahoo! Finance Canada
MGTX SEC FilingsMeiragtx Holdings Plc 10-K, 10-Q, 8-K Forms - Stock Titan
MeiraGTx Holdings PLC (MGTX) Q4 earnings and revenues surpass estimates - MSN
Piper Sandler cuts MeiraGTx stock price target on valuation By Investing.com - Investing.com Australia
Piper Sandler Lowers MeiraGTx (NASDAQ:MGTX) Price Target to $26.00 - MarketBeat
Piper Sandler cuts MeiraGTx stock price target on valuation - Investing.com UK
MeiraGTx (NASDAQ:MGTX) Issues Earnings Results - MarketBeat
MeiraGTx (NASDAQ:MGTX) Price Target Raised to $16.00 at Bank of America - MarketBeat
MeiraGTx (NASDAQ:MGTX) Earns Buy Rating from Chardan Capital - MarketBeat
MeiraGTx Receives FDA Breakthrough Therapy Designation for AAV2-hAQP1 and Reports Strong 2025 Financial Results - Minichart
BofA raises MeiraGTx stock price target to $16 on FDA designation - uk.investing.com
BofA raises MeiraGTx stock price target to $16 on FDA designation By Investing.com - Investing.com India
MeiraGTx Highlights Breakthrough Gene Therapy and Strategic Alliances - TipRanks
MeiraGTx (NASDAQ:MGTX) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Finanzdaten der Meiragtx Holdings Plc-Aktie (MGTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.69%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):